Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of GW906 (SAL0132) Injection in Patients With Essential Hypertension

NCT07879755 is registered in ClinicalTrials.gov with Shenzhen Salubris Pharmaceuticals Co., Ltd. as lead sponsor.

NCT NCT07879755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07879755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of GW906 (SAL0132) Injection in Patients With Essential Hypertension
Lead sponsor
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 12, 2026
Completion date
January 30, 2029
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension